| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-08 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-07 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-07 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-06 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-06 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |